- Home
- Publications
- Publication Search
- Publication Details
Title
Biologic treatments for adult-onset Still's disease
Authors
Keywords
-
Journal
RHEUMATOLOGY
Volume 53, Issue 1, Pages 32-38
Publisher
Oxford University Press (OUP)
Online
2013-07-18
DOI
10.1093/rheumatology/ket250
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL-1 Trap rilonacept in refractory adult onset Still's disease
- (2012) Olga Petryna et al. ANNALS OF THE RHEUMATIC DISEASES
- Successful treatment of adult-onset Still’s disease with tocilizumab monotherapy: two case reports and literature review
- (2012) Ryota Sakai et al. CLINICAL RHEUMATOLOGY
- Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence
- (2012) Hubert de Boysson et al. CLINICAL RHEUMATOLOGY
- Refractory Adult-Onset Still Disease Successfully Treated With Abatacept
- (2012) Rochella A. Ostrowski et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Beneficial Effect of Interleukin 1 Inhibition with Anakinra in Adult-onset Still's Disease. An Open, Randomized, Multicenter Study
- (2012) D. NORDSTROM et al. JOURNAL OF RHEUMATOLOGY
- The Use of Canakinumab, a Novel IL-1β Long-Acting Inhibitor, in Refractory Adult-Onset Still's Disease
- (2012) Apostolos Kontzias et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Anakinra in Adult-Onset Still's Disease: Long-Term Treatment in Patients Resistant to Conventional Therapy
- (2012) Cecilia Giampietro et al. ARTHRITIS CARE & RESEARCH
- Is anti-TNF switching in refractory Still’s disease safe and effective?
- (2011) Nadia Emi Aikawa et al. CLINICAL RHEUMATOLOGY
- Tocilizumab Improved both Clinical and Laboratory Manifestations Except for Interleukin-18 in a Case of Multiple Drug-Resistant Adult-Onset Still's Disease
- (2011) Yoshihiro Yoshida et al. INTERNAL MEDICINE
- Therapeutic response of patients with adult Still’s disease to biologic agents: multicenter results in Japan
- (2011) Rie Suematsu et al. Modern Rheumatology
- Treatment of refractory adult-onset still’s disease with tocilizumab: report of two cases and review of the literature
- (2011) Rene Thonhofer et al. RHEUMATOLOGY INTERNATIONAL
- Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study
- (2011) Katerina Laskari et al. ARTHRITIS RESEARCH & THERAPY
- IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease
- (2010) L Naumann et al. ANNALS OF THE RHEUMATIC DISEASES
- Successful treatment of adult-onset Still's disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade
- (2010) J. Rech et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still's disease
- (2010) Stefano Franchini et al. ARTHRITIS AND RHEUMATISM
- Etanercept-refractory adult-onset Still’s disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab
- (2010) Keiichi Sumida et al. CLINICAL RHEUMATOLOGY
- A case of refractory adult-onset Still’s disease successfully controlled with tocilizumab and a review of the literature
- (2010) Katja Perdan-Pirkmajer et al. CLINICAL RHEUMATOLOGY
- Case report: successful use of short-term add-on tocilizumab for multirefractory systemic flare of adult-onset Still’s disease
- (2010) Taio Naniwa et al. CLINICAL RHEUMATOLOGY
- May anakinra be used earlier in adult onset Still disease?
- (2010) Guillaume Moulis et al. CLINICAL RHEUMATOLOGY
- A case of refractory adult-onset Still’s disease treated with anakinra
- (2010) Manjari LAHIRI et al. International Journal of Rheumatic Diseases
- Adult-onset Still's disease with myocarditis successfully treated with the interleukin-1 receptor antagonist anakinra
- (2010) Bernd Raffeiner et al. JOINT BONE SPINE
- Benefit and a possible risk of tocilizumab therapy for adult-onset Still’s disease accompanied by macrophage-activation syndrome
- (2010) Masafumi Kobayashi et al. Modern Rheumatology
- Successful tocilizumab treatment in a patient with adult-onset Still’s disease complicated by chronic active hepatitis B and amyloid A amyloidosis
- (2010) Dai Kishida et al. Modern Rheumatology
- Tocilizumab in Refractory Adult-Onset Still's Disease with Aseptic Meningitis—Efficacy of Interleukin-6 Blockade and Review of the Literature
- (2010) Girish R. Sabnis et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- A 21-year-old man with Still's disease with fever, rash, and pancytopenia
- (2010) Bijal M. Mehta et al. ARTHRITIS CARE & RESEARCH
- Tocilizumab in refractory adult Still's disease
- (2010) Xavier Puéchal et al. ARTHRITIS CARE & RESEARCH
- A patient's wish: anakinra in pregnancy
- (2009) C T Berger et al. ANNALS OF THE RHEUMATIC DISEASES
- Glucocorticoid and cyclosporine refractory adult onset Still’s disease successfully treated with tocilizumab
- (2009) Kazuko Matsumoto et al. CLINICAL RHEUMATOLOGY
- Marked effect and steroid-sparing ability of anakinra on a patient with refractory adult-onset Still’s disease
- (2009) Hiromichi Tamaki et al. Modern Rheumatology
- Myocarditis as a form of relapse in two patients with adult Still’s disease
- (2009) Javier Alberto Cavallasca et al. RHEUMATOLOGY INTERNATIONAL
- A rare trigger for macrophage activation syndrome
- (2009) Shikhar Agarwal et al. RHEUMATOLOGY INTERNATIONAL
- Tocilizumab for multirefractory adult-onset Still's disease
- (2008) M De Bandt et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy of Anakinra in a Case of Refractory Still Disease
- (2008) Severine Debiais et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Adult-onset Still’s disease: a report of 28 cases and review of the literature
- (2008) Golbarg Mehrpoor et al. Modern Rheumatology
- A case report of a patient with refractory adult-onset Still’s disease who was successfully treated with tocilizumab over 6 years
- (2008) Hideko Nakahara et al. Modern Rheumatology
- Etanercept as a rescue agent in patient with adult onset Still’s disease complicated with congestive heart failure
- (2008) Deng-Ho Yang et al. RHEUMATOLOGY INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started